GUMDROP : JHMI - A Neoadjuvant Immunologic Study of Androgen Deprivation Therapy Combined With a GM-CSF-secreting Allogeneic Prostate Cancer Vaccine and Low-dose Cyclophosphamide in Men With High-risk Localized Prostate Cancer Undergoing Radical Prostatectomy

Created by Nancy Dawson, last modified on Jun 25, 2013
Description:This research is being done to see if an investigational prostate cancer vaccine, called GVAX, can safely be given together with a single intravenous injection of a drug called cyclophosphamide to men that will undergo surgery to remove their cancerous prostate glands who have also received standard hormonal therapy.
Link:http://clinicaltrials.gov/ct2/show/NCT01696877
Site:Johns Hopkins University
Principal Investigator:Emmanuel Antonarakis, MD